ImmunityBio (IBRX) EBT Margin Growth (3y) (2017 - 2026)
Powered by 
Analysis
ImmunityBio (IBRX) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -5,319.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,363.00 |
| 10 | ImmunityBio | 8.45 Bn | 8.10 Bn | 50.94 Mn | 33.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.67 Mn |
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 14.82 Mn |
| Sep 30, 2025 | 9.40 Mn |
| Jun 30, 2025 | 27.06 Mn |
| Mar 31, 2025 | 73.49 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 13.26 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | -27.74 Mn |
| Dec 31, 2023 | 15.96 Mn |
| Sep 30, 2023 | -7.17 Mn |
| Jun 30, 2023 | -32.52 Mn |
| Mar 31, 2023 | -971,205.00 |
| Dec 31, 2022 | 107.48 Mn |
| Sep 30, 2022 | 3.56 Mn |
| Jun 30, 2022 | -17.28 Mn |
| Mar 31, 2022 | -37.73 Mn |
| Dec 31, 2021 | 22.61 Mn |
| Sep 30, 2021 | -5.73 Mn |